Can't say I disagree with you. I'll be selling some on the day this gets approved, and getting back in a few months before FDA approval (whenever that comes). But I'm not giving this company another 4 years of my life waiting on vitiligo after all this.
Give me a mgmt team that keeps its timelines and provides a decent long-term ROI.
cuv9900 is not a patch - it appears to be some topical formulation. Starting a safety trial for it isn't going to deter the EMA from approving the implant for EPP.
Can't say I disagree with you. I'll be selling some on the day...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.37 |
Change
0.130(0.85%) |
Mkt cap ! $770.0M | |||
| Open | High | Low | Value | Volume |
| $15.36 | $15.54 | $15.18 | $1.274M | 82.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237 | $15.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 282 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |